|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 90.48 USD | +0.60% |
|
+1.93% | -8.15% |
| Apr. 15 | Liberty Formula One Set for Solid Q1 as Sponsorship Momentum, Margins Improve, UBS Says | MT |
| Apr. 15 | UBS Cuts Formula One Price Target to $104 From $107, Maintains Neutral Rating | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.22 | 0.95 | 1.74 | 2.22 | 2.66 | |||||
Return on Total Capital | 0.24 | 1.06 | 1.93 | 2.48 | 3.19 | |||||
Return On Equity % | -1.78 | 8.1 | 2.76 | -0.43 | 7.69 | |||||
Return on Common Equity | -2.95 | 8.42 | 2.78 | -0.43 | 8.06 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 30.29 | 31.99 | 30.48 | 31.89 | 33.71 | |||||
SG&A Margin | 9.83 | 11.19 | 9.81 | 11.17 | 11.47 | |||||
EBITDA Margin % | 20.46 | 20.79 | 20.67 | 20.37 | 22.24 | |||||
EBITA Margin % | 1.87 | 6.72 | 9.22 | 18.67 | 20.66 | |||||
EBIT Margin % | 1.87 | 6.72 | 9.22 | 10.73 | 13.48 | |||||
Income From Continuing Operations Margin % | -5.62 | 21.84 | 5.71 | -0.82 | 13.3 | |||||
Net Income Margin % | -8.9 | 21.69 | 5.74 | -0.82 | 12.38 | |||||
Net Avail. For Common Margin % | -8.9 | 21.69 | 5.74 | -0.82 | 13.3 | |||||
Normalized Net Income Margin | -5.24 | 4.63 | 3.83 | 2.09 | 10.6 | |||||
Levered Free Cash Flow Margin | 35.59 | 10.8 | -0.59 | 18.4 | 14.82 | |||||
Unlevered Free Cash Flow Margin | 39.19 | 14.42 | 3.56 | 21.95 | 18.86 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.19 | 0.23 | 0.3 | 0.33 | 0.32 | |||||
Fixed Assets Turnover | 17.58 | 9.76 | 5.17 | 4.43 | 5.34 | |||||
Receivables Turnover (Average Receivables) | 22.84 | 27.23 | 26.2 | 28 | 17.96 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.83 | 2.43 | 2.17 | 2.67 | 1.46 | |||||
Quick Ratio | 1.65 | 2.23 | 1.95 | 2.43 | 1.37 | |||||
Operating Cash Flow to Current Liabilities | 0.37 | 0.64 | 0.79 | 0.5 | 0.93 | |||||
Days Sales Outstanding (Average Receivables) | 15.98 | 13.41 | 13.93 | 13.07 | 20.32 | |||||
Average Days Payable Outstanding | 56.13 | 73.42 | 75.85 | 82.16 | 75.19 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 52.32 | 42.49 | 45.27 | 41.09 | 60.64 | |||||
Total Debt / Total Capital | 34.35 | 29.82 | 31.16 | 29.12 | 37.75 | |||||
LT Debt/Equity | 42.31 | 41.61 | 44.71 | 40.54 | 59.96 | |||||
Long-Term Debt / Total Capital | 27.77 | 29.2 | 30.78 | 28.73 | 37.33 | |||||
Total Liabilities / Total Assets | 40.5 | 37.05 | 37.48 | 37.17 | 45.12 | |||||
EBIT / Interest Expense | 0.33 | 1.16 | 1.39 | 1.88 | 2.08 | |||||
EBITDA / Interest Expense | 3.55 | 3.59 | 3.11 | 3.88 | 3.66 | |||||
(EBITDA - Capex) / Interest Expense | 3.41 | 1.64 | 1.12 | 3.51 | 3.25 | |||||
Total Debt / EBITDA | 8.31 | 5.51 | 4.36 | 3.77 | 4.82 | |||||
Net Debt / EBITDA | 3.56 | 2.27 | 2.25 | 0.5 | 3.83 | |||||
Total Debt / (EBITDA - Capex) | 8.65 | 12.08 | 12.11 | 4.15 | 5.43 | |||||
Net Debt / (EBITDA - Capex) | 3.71 | 4.98 | 6.24 | 0.55 | 4.31 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 86.55 | 20.46 | 25.22 | 13.38 | 22.69 | |||||
Gross Profit, 1 Yr. Growth % | 278.36 | 27.2 | 19.32 | 18.64 | 29.7 | |||||
EBITDA, 1 Yr. Growth % | -14.67K | 22.43 | 24.49 | 11.71 | 34.01 | |||||
EBITA, 1 Yr. Growth % | -109.01 | 332.5 | 71.68 | 129.63 | 35.78 | |||||
EBIT, 1 Yr. Growth % | -109.01 | 332.5 | 71.68 | 31.99 | 54.08 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -79.8 | -568.33 | -67.26 | -116.3 | -1.45K | |||||
Net Income, 1 Yr. Growth % | -68.12 | -393.68 | -66.85 | -116.22 | -126.9 | |||||
Normalized Net Income, 1 Yr. Growth % | -66.99 | -206.48 | 3.67 | -38.26 | -0.55 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -68.09 | -361.9 | -71.29 | -121.08 | -1.77K | |||||
Accounts Receivable, 1 Yr. Growth % | -45.45 | 86.36 | 0 | -7.32 | 0.44 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -4.03 | 242.86 | 105.39 | -3.34 | 7.16 | |||||
Total Assets, 1 Yr. Growth % | 4.23 | -5.56 | -6.8 | 14.53 | 18.44 | |||||
Tangible Book Value, 1 Yr. Growth % | -12.8 | -81.41 | 89 | -243.04 | -2.22K | |||||
Common Equity, 1 Yr. Growth % | -3.21 | 8.99 | -7.11 | 15.1 | 10.36 | |||||
Cash From Operations, 1 Yr. Growth % | -446.04 | 11.02 | 15.92 | -8.4 | -39.37 | |||||
Capital Expenditures, 1 Yr. Growth % | -19.05 | 1.61K | 46.39 | -82.39 | 58.67 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -362.34 | -63.43 | -106.88 | -3.61K | 54.7 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -521.66 | -55.66 | -69.11 | 599.67 | 70.81 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 2.78 | 49.91 | 22.82 | 19.15 | 12.02 | |||||
Gross Profit, 2 Yr. CAGR % | 1.5 | 119.38 | 23.2 | 18.98 | 6.51 | |||||
EBITDA, 2 Yr. CAGR % | 2.25 | 1.24K | 23.45 | 17.93 | 21.71 | |||||
EBITA, 2 Yr. CAGR % | 6.9 | -37.58 | 172.49 | 98.55 | 24.86 | |||||
EBIT, 2 Yr. CAGR % | 6.9 | -37.58 | 172.49 | 50.53 | 50.41 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -37.88 | -2.73 | 23.83 | -76.9 | 185.73 | |||||
Net Income, 2 Yr. CAGR % | -21.84 | -3.24 | -1.32 | -76.81 | -14.6 | |||||
Normalized Net Income, 2 Yr. CAGR % | -36.93 | -40.71 | 5.07 | -19.99 | 121 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -22.06 | -8.59 | -13.28 | -75.4 | 99.38 | |||||
Accounts Receivable, 2 Yr. CAGR % | -2.2 | 0.82 | 36.52 | -3.73 | 36.45 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 3.08 | 81.39 | 165.37 | 40.9 | 1.77 | |||||
Total Assets, 2 Yr. CAGR % | 0.69 | -0.78 | -6.18 | 3.32 | 22.46 | |||||
Tangible Book Value, 2 Yr. CAGR % | -38.99 | -59.73 | -40.72 | 64.42 | 232.62 | |||||
Common Equity, 2 Yr. CAGR % | 10.01 | 2.71 | 0.62 | 3.4 | 9.93 | |||||
Cash From Operations, 2 Yr. CAGR % | 27.91 | 96 | 13.44 | 3.04 | -40.58 | |||||
Capital Expenditures, 2 Yr. CAGR % | -37.84 | 272.25 | 400.59 | -49.23 | -49.19 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 47.74 | -2.05 | -84.14 | 55.48 | 427.47 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 33.43 | 36.74 | -62.99 | 47 | 183.94 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 5.35 | 8.36 | 41.18 | 19.59 | 20.32 | |||||
Gross Profit, 3 Yr. CAGR % | 5.31 | 9.43 | 79.08 | 21.66 | 22.45 | |||||
EBITDA, 3 Yr. CAGR % | 7.68 | 8.57 | 505.5 | 19.41 | 23.06 | |||||
EBITA, 3 Yr. CAGR % | -28.62 | 70.34 | -12.54 | 157.38 | 74.93 | |||||
EBIT, 3 Yr. CAGR % | -28.62 | 70.34 | -12.54 | 114 | 51.7 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -7.17 | 21.8 | -32.34 | -37 | 1.98 | |||||
Net Income, 3 Yr. CAGR % | 8.2 | 21.51 | -32.29 | -45.95 | -0.18 | |||||
Normalized Net Income, 3 Yr. CAGR % | -7.2 | -24.9 | -28.57 | -12 | 58.57 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 8.05 | 16.74 | -37.86 | -45.88 | 0.42 | |||||
Accounts Receivable, 3 Yr. CAGR % | -15.66 | 21.25 | 0.55 | 19.98 | 23.02 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.76 | 53.87 | 89.06 | 89.52 | 28.61 | |||||
Total Assets, 3 Yr. CAGR % | 2.11 | -1.44 | -2.83 | 0.27 | 11.81 | |||||
Tangible Book Value, 3 Yr. CAGR % | -29.01 | -58.94 | -32.58 | -20.49 | 175.49 | |||||
Common Equity, 3 Yr. CAGR % | 4.54 | 9.67 | -0.67 | 5.23 | 3.93 | |||||
Cash From Operations, 3 Yr. CAGR % | 21.53 | 22.01 | 64.52 | 5.64 | 17.67 | |||||
Capital Expenditures, 3 Yr. CAGR % | 6.69 | 87.71 | 172.73 | 64.01 | -25.77 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 27.79 | -7.23 | -59.59 | -4.02 | 33.69 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 20.01 | -7.58 | -16.73 | -1.41 | 31.58 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | - | 7.61 | 12.02 | 12.56 | 31.38 | |||||
Gross Profit, 5 Yr. CAGR % | - | 7.85 | 12.13 | 13.15 | 54.62 | |||||
EBITDA, 5 Yr. CAGR % | 49.77 | 7.95 | 13.73 | 12.22 | 219.39 | |||||
EBITA, 5 Yr. CAGR % | -10.07 | 34.03 | 21.98 | 81.11 | 15.84 | |||||
EBIT, 5 Yr. CAGR % | -10.07 | 34.03 | 21.98 | 62.12 | 6.35 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -18.27 | 16.94 | 4.17 | -37.36 | 0.07 | |||||
Net Income, 5 Yr. CAGR % | -10.4 | 16.96 | 4.28 | -37.36 | -1.42 | |||||
Normalized Net Income, 5 Yr. CAGR % | 36.34 | -9.97 | -2.48 | -22.98 | 6.99 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -26.89 | 12.16 | -1.05 | -37.38 | -3.29 | |||||
Accounts Receivable, 5 Yr. CAGR % | - | 7.93 | 2.26 | 10.56 | 13.61 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 5.98 | 33.84 | 56.24 | 48.54 | 47.58 | |||||
Total Assets, 5 Yr. CAGR % | 31.25 | -1.37 | -1.29 | 0.44 | 6.59 | |||||
Tangible Book Value, 5 Yr. CAGR % | -2.64 | -42.95 | -33.95 | -28.48 | 27.66 | |||||
Common Equity, 5 Yr. CAGR % | 37.58 | 4.04 | 2.95 | 7.12 | 3.44 | |||||
Cash From Operations, 5 Yr. CAGR % | 4.94 | 48.08 | 18.23 | 14.04 | 44.31 | |||||
Capital Expenditures, 5 Yr. CAGR % | 53.42 | 96.24 | 98 | 11.26 | 41.47 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 41.16 | -5.48 | -44.53 | 14.05 | 18.05 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 41.51 | -6.01 | -25.04 | 11.27 | 33.62 |
- Stock Market
- Equities
- FWONK Stock
- Financials Formula One Group
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















